Kalaris Therapeutics, Inc. - KLRS
CEO
Director
10% owner
Officer Title: President, Chief Financial Officer
Direct Buys
0
$0
0
Shares
Direct Sells
14
($26,133)
-29,993
Shares
Indirect Buys
0
$0
0
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
02/21/2025
|
02/24/2025 |
Sell
|
-303 @ $10.08
|
($3,053) | 49,129 (-0.61%) | Direct |
|
01/23/2025
|
01/27/2025 |
Sell
|
-129 @ $9.50
|
($1,226) | 49,432 (-0.26%) | Direct |
|
01/10/2025
|
01/13/2025 |
Sell
|
-979 @ $0.44
|
($431) | 1,139,915 (-0.09%) | Direct |
|
11/19/2024
|
11/20/2024 |
Sell
|
-3,186 @ $0.55
|
($1,748) | 1,140,894 (-0.28%) | Direct |
|
11/05/2024
|
11/06/2024 |
Sell
|
-5,136 @ $0.86
|
($4,442) | 1,144,080 (-0.45%) | Direct |
|
10/22/2024
|
10/23/2024 |
Sell
|
-1,882 @ $0.77
|
($1,445) | 1,149,216 (-0.16%) | Direct |
|
10/21/2024
|
10/23/2024 |
Sell
|
-1,546 @ $0.78
|
($1,204) | 1,151,098 (-0.13%) | Direct |
|
10/03/2024
|
10/04/2024 |
Sell
|
-940 @ $0.81
|
($766) | 1,152,644 (-0.08%) | Direct |
|
08/19/2024
|
08/20/2024 |
Sell
|
-3,159 @ $0.76
|
($2,399) | 1,153,584 (-0.27%) | Direct |
|
08/05/2024
|
08/07/2024 |
Sell
|
-5,251 @ $0.73
|
($3,858) | 1,156,743 (-0.45%) | Direct |
|
07/22/2024
|
07/23/2024 |
Sell
|
-1,858 @ $0.74
|
($1,373) | 1,161,994 (-0.16%) | Direct |
|
07/19/2024
|
07/23/2024 |
Sell
|
-1,542 @ $0.75
|
($1,157) | 1,163,852 (-0.13%) | Direct |
|
07/02/2024
|
07/03/2024 |
Sell
|
-939 @ $0.72
|
($676) | 1,165,394 (-0.08%) | Direct |
|
05/17/2024
|
05/21/2024 |
Sell
|
-3,143 @ $0.75
|
($2,355) | 1,129,996 (-0.28%) | Direct |